In this study we employed the specific VCP inhibitor CB-5083 to demonstrate that inhibition of VCP in AML cells leads to accumulation of ubiquitylated proteins, activation of the UPR and reduces survival of multiple AML cells lines. This evidence concerns the gene VCP and acute myeloid leukemia.